Children's Hospital Association submitted comments on the cell and gene therapy request for information (RFI) from Sen. Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Our response highlights the need to ensure children’s equitable access to these therapies and a strong national framework for payment and oversight.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
Related Content
Community Impact Drives Trust in Children's Hospitals
CHA Applauds Inclusion of Vital Children’s Health Policies in FY26 Funding Package
Protecting Children’s Access to Care: H.R. 1 Mitigation-Related Resources
Community Impact Drives Trust in Children's Hospitals
A new consumer survey shows what drives public trust in children’s hospitals.
Feb. 05, 2026
CHA Applauds Inclusion of Vital Children’s Health Policies in FY26 Funding Package
The package includes policies and funding that will increase access to care for children and support pediatric workforce resilience.
Feb. 03, 2026
Protecting Children’s Access to Care: H.R. 1 Mitigation-Related Resources
H.R. 1 makes significant changes to the Medicaid program and includes policies that will limit children’s access to care.
Feb. 03, 2026
